Adenine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00173 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | drug-induced osteoporosis | KG + DL |
| 2 | colonic neoplasm | KG + DL |
| 3 | acne (disease) | KG + DL |
| 4 | rectosigmoid junction neoplasm | KG + DL |
| 5 | lipoma of colon | KG + DL |
| 6 | colonic lymphangioma | KG + DL |
| 7 | cecum villous adenoma | KG + DL |
| 8 | cavernous hemangioma of colon | KG + DL |
| 9 | cecum neuroendocrine tumor G1 | KG + DL |
| 10 | cecal disease | KG + DL |
| 11 | colon leiomyoma | KG + DL |
| 12 | benign neoplasm of cecum | KG + DL |
| 13 | urinary bladder neoplasm | KG + DL |
| 14 | multiple endocrine neoplasia | KG + DL |
| 15 | bladder squamous papilloma | KG + DL |
| 16 | malignant catarrh | KG + DL |
| 17 | infectious bovine rhinotracheitis | KG + DL |
| 18 | bladder urothelial papilloma | KG + DL |
| 19 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 20 | hyperthyroidism | KG + DL |
| 21 | bladder leiomyoma | KG + DL |
| 22 | urinary bladder cancer | KG + DL |
| 23 | amenorrhea (disease) | KG + DL |
| 24 | pregnancy associated osteoporosis | KG + DL |
| 25 | squamous cell carcinoma of colon | KG + DL |
| 26 | ureteric orifice cancer | KG + DL |
| 27 | non-syndromic visceral malformation | KG + DL |
| 28 | urinary system neoplasm | KG + DL |
| 29 | postmenopausal osteoporosis | KG + DL |
| 30 | colorectal gastrointestinal stromal tumor | KG + DL |
| 31 | cytomegalovirus infection | KG + DL |
| 32 | colorectal hamartoma | KG + DL |
| 33 | colorectal leiomyoma | KG + DL |
| 34 | biliary atresia intrahepatic | KG + DL |
| 35 | Worth syndrome | KG + DL |
| 36 | urinary bladder carcinoma | KG + DL |
| 37 | Mirizzi syndrome | KG + DL |
| 38 | cholestasis | KG + DL |
| 39 | non-papillary transitional cell carcinoma of the bladder | KG + DL |
| 40 | autosomal dominant neovascular inflammatory vitreoretinopathy | KG + DL |
| 41 | bladder urachal adenocarcinoma | KG + DL |
| 42 | bladder carcinoma in situ | KG + DL |
| 43 | succinyl-CoA:3-ketoacid CoA transferase deficiency | KG + DL |
| 44 | hyperthyroxinemia | KG + DL |
| 45 | infiltrating bladder urothelial carcinoma | KG + DL |
| 46 | common wart | KG + DL |
| 47 | bladder signet ring cell adenocarcinoma | KG + DL |
| 48 | non-invasive bladder urothelial carcinoma | KG + DL |
| 49 | bladder colloid adenocarcinoma | KG + DL |
| 50 | bladder colonic type adenocarcinoma | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.